Crossref
CON: Systemic Therapy for All Endometrial Carcinomas Should Not be Paclitaxel Plus Carboplatin
Clinical Ovarian Cancer · 2011
DOI: 10.1016/j.cloc.2012.02.017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Ovarian Cancer, 2011. Verfasst von J. Tate Thigpen. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Thigpen, J. T. (2011). CON: Systemic Therapy for All Endometrial Carcinomas Should Not be Paclitaxel Plus Carboplatin. Clinical Ovarian Cancer. https://doi.org/10.1016/j.cloc.2012.02.017
Vancouver
Thigpen JT. CON: Systemic Therapy for All Endometrial Carcinomas Should Not be Paclitaxel Plus Carboplatin. Clinical Ovarian Cancer. 2011. doi:10.1016/j.cloc.2012.02.017
BibTeX
@article{Thigpen2011,
author = {Thigpen, J. Tate},
title = {CON: Systemic Therapy for All Endometrial Carcinomas Should Not be Paclitaxel Plus Carboplatin},
journal = {Clinical Ovarian Cancer},
year = {2011},
doi = {10.1016/j.cloc.2012.02.017}
}
EUVIMED